DB Changes PT And EPS Estimates Of Valeant

by BenzingaStaffB, Benzinga Staff Writer
August 5, 2011 9:07 AM | 13 seconds read |
According to DB, Valeant Pharmaceuticals VRX, PT and EPS estimates have changed. DB reported a decrease in the PT from $64.00 to $57.00 and a change in EPS estimates from $2.78 to $2.84. Valeant closed yesterday at $40.85.
Market News and Data brought to you by Benzinga APIs

© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Comments
Posted In: Analyst ColorAnalyst RatingsDeutsche BankHealth CarePharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!